Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections
This study has been completed.
Sponsor:
Almirall, S.A.
Information provided by (Responsible Party):
Almirall, S.A.
ClinicalTrials.gov Identifier:
NCT01102387
First received: March 30, 2010
Last updated: July 3, 2012
Last verified: January 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2011 |
| Primary Completion Date: | July 2011 (Final data collection date for primary outcome measure) |